1996
DOI: 10.1136/bmj.313.7061.844
|View full text |Cite
|
Sign up to set email alerts
|

Value of thallium-201 imaging in detecting adverse cardiac events after myocardial infarction and thrombolysis: a follow up of 100 consecutive patients

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

0
7
1

Year Published

1997
1997
2009
2009

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(8 citation statements)
references
References 24 publications
0
7
1
Order By: Relevance
“…[19][20][21] In the present study, however, cardiac function in the subacute phase was not identified as a predictor of cardiac and cerebrovascular events. In this study, primary angioplasty was successful in all patients and patients with cardiac events during the acute phase were excluded.…”
Section: )contrasting
confidence: 39%
“…[19][20][21] In the present study, however, cardiac function in the subacute phase was not identified as a predictor of cardiac and cerebrovascular events. In this study, primary angioplasty was successful in all patients and patients with cardiac events during the acute phase were excluded.…”
Section: )contrasting
confidence: 39%
“…Both peak creatine kinase levels [23] and a high severity score by thallium scintigraphy [24,25] are predictors of poor clinical outcomes. The implication of our results therefore is that preintervention IVUS may be able to predict long-term patient outcomes before primary angioplasty.…”
Section: Discussionmentioning
confidence: 99%
“…Post-ACS risk assessment strategies need to be more aggressive, and pharmacologically stressed myocardial perfusion imaging 9 may be a good initial option for physically disabled patients unable to have exercise testing, as it is a highly sensitive and specific tool for predicting ACS recurrence in the general population. 45 Rheumatoid patients should not be discriminated against from early intervention with coronary angioplasty and stenting. Strategies involving traditional antirheumatic drugs aimed at effectively controlling systemic inflammation and thus improving plaque stabilisation may already be reducing risk, 46 but additional cardiovascular drugs-for example statins 47 -need to be investigated prospectively in this high risk group.…”
Section: Discussionmentioning
confidence: 99%